Photo of the meeting between Family, Community Pharmacy and the Aemps.
Representatives of the Spanish Society of Clinical, Family and Community Pharmacy (Sefak), the Spanish Society of Primary Care Physicians (Semerge) and the Spanish Society of General and Family Physicians (SEMG) have held a meeting with the director of the Spanish Agency for Medicines and Health Products (Aemps)María Jesús Lamas, with the aim of transferring the position that the three scientific societies issued on September 26 (World Contraception Day) to progress in dispensing without a prescription of the progestogen-only oral contraceptives.
The meeting was attended by Eduardo Satué, 2nd Vice President of SEFAC; Neus Caelles, member of the Women’s Health Group; María Blasco, coordinator of the Semergen Women’s Care Group; Lorenzo Armenteros, head of the SEMG Women’s Health Area, with María Jesús Lamas, director of Aemps, and Antonio López, head of the Aemps Management Support Unit.
What do Family and Pharmacy ask of the Aemps?
The representatives of the medical and pharmaceutical scientific societies have explained to the director of the Aemps the content of the position and the arguments for which they request that oral contraceptives with only gestagens be dispensed without the need for a medical prescription in community pharmacies.
The objective of this position is to support the empowerment of women to decide on their sexual and reproductive health and facilitate access to contraceptive methods as a fundamental element for improve family planning.
The three scientific societies defend that contraception is not a health problem, so it cannot be approached as a disease, and there are currently barriers that make access difficult and that put at risk the ability of women to decide about their health. sexual and reproductive.
In fact, the World Health Organization (WHO) recognizes contraception as an essential element for family planning. For these reasons, Sefac, Semergen and SEMG support the over-the-counter dispensing of some oral contraceptives, such as progestin-only contraceptives, as they have an adequate safety profile and are not associated with serious side effects.
For scientific societies, the presence of the community pharmacist offers an additional security guarantee, since it can assess their situation with the women who are going to use the contraceptive and guide them to offer the most appropriate solution, as is the case with emergency contraception, and coordinate with the doctor when appropriate.
In this sense, the communication and referral to the doctor, when necessary, would be the necessary step to increase access to contraception and promote contraceptive success. In addition, this measure would contribute to reducing the care overload of primary care consultations, being able to direct the medical effort towards more relevant clinical needs.
Although it may contain statements, data or notes from health institutions or professionals, the information contained in Medical Writing is edited and prepared by journalists. We recommend the reader that any questions related to health be consulted with a health professional.